Search results
Results from the WOW.Com Content Network
An alpha privative or, rarely, [1] privative a (from Latin alpha prīvātīvum, from Ancient Greek α στερητικόν) is the prefix a-or an-(before vowels) that is used in Indo-European languages such as Sanskrit and Greek and in words borrowed therefrom to express negation or absence, for example the English words of Greek origin atypical, anesthetic, and analgesic.
Meaning Origin language and etymology Example(s) -iasis: condition, formation, or presence of Latin -iasis, pathological condition or process; from Greek ἴασις (íasis), cure, repair, mend mydriasis: iatr(o)-of or pertaining to medicine or a physician (uncommon as a prefix but common as a suffix; see -iatry)
a-, called alpha privative, from Ancient Greek ἀ-, ἀν-, from Proto-Hellenic *ə-; e.g. apathetic, abiogenesis. These all stem from a PIE syllabic nasal privative *n̥-, the zero ablaut grade of the negation *ne, i.e. "n" used as a vowel, as in some English pronunciations of "button". This is the source of the 'n' in 'an-' privative ...
Anisogamy (the opposite of isogamy) comes from the ancient Greek negative prefix a(n)-(alpha privative), the Greek adjective isos (meaning equal) and the Greek verb gameo (meaning to have sex/to reproduce), eventually meaning "non-equal reproduction" obviously referring to the enormous differences between male and female gametes in size and abilities. [10]
Myanmar Medical Journal: Medicine: Myanmar Medical Association: English: 1953–present Nano Biomedicine and Engineering: Medicine: Open-Access House of Science and Technology: English: 2009–present National Medical Journal of India: Medicine: All India Institute of Medical Sciences, New Delhi: English: 1988–present Nature Medicine ...
Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. [1] It has the potential to provide highly targeted treatment, especially to microscopic tumour cells.
Benji was making progress about three years ago. For more than 33 hours a week in the specialized therapy, his clinicians broke down the learning process into basic steps, using repetition and ...
Richard Smith, the former editor of the medical journal the BMJ, has been critical of many of the aspects of modern-day medical journal publishing. [5] [12] Critics of medical publishing have argued that problems related to gaming of citation and authorship are prevalent in the field, as many authors did not actually contribute to the articles that their names are on, many contributors to the ...